H13 anticorps (AA 251-350) (Cy5.5)

N° du produit ABIN1407629

Détail du produit anti-H13 anticorps (Cy5.5)

Antigène: H13 (Histocompatibility 13 (H13))

Épitope: AA 251-350

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp H13 est conjugé à/à la Cy5.5

Application: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Homologie: Human,Mouse,Rat,Dog,Cow,Pig,Horse,Chicken,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human Signal Peptide Peptidase

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur H13

Antigène: H13 (Histocompatibility 13 (H13))

Autre désignation: Spp/Signal Peptide Peptidase (H13 Produits)

Sujet:

Synonyms: Histocompatibility minor 13, HM 13, HM13, HM13_HUMAN, IMP 1, IMP-1, IMP1, IMPAS, IMPAS-1, Intramembrane Protease 1, Intramembrane protease, Minor Histocompatibility 13, Minor histocompatibility antigen 13, Minor histocompatibility antigen H13, MSTP086, Presenilin like protein 3, Presenilin-like protein 3, PSENL 3, PSENL3, PSL 3, PSL3, Signal peptide peptidase, Signal peptide peptidase beta, SPP, dJ324O17.1, H13, hIMP1, hIMP1 protein.

Background: The endoplasmic reticulum exerts a quality control over newly synthesized proteins and a variety of components have been implicated in the specific recognition of aberrant or misfolded polypeptides. Signal peptide peptidase (SPP) catalyzes intramembrane proteolysis of some signal peptides after they have been cleaved from a preprotein, resulting in the release of the fragment from the ER membrane into the cytoplasm. SPP is required to generate lymphocyte cell surface (HLA-E) epitopes derived from MHC class I signal peptides, and may play a role in graft rejection. It also may be necessary for the removal of the signal peptide that remains attached to the hepatitis C virus core protein after the initial proteolytic processing of the polyprotein.

ID gène: 207